rs1554263624
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PP2PP5_Very_Strong
The NM_006908.5(RAC1):c.116A>G(p.Asn39Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006908.5 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, autosomal dominant 48Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Illumina, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006908.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RAC1 | NM_006908.5 | MANE Select | c.116A>G | p.Asn39Ser | missense | Exon 3 of 6 | NP_008839.2 | ||
| RAC1 | NM_018890.4 | c.116A>G | p.Asn39Ser | missense | Exon 3 of 7 | NP_061485.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RAC1 | ENST00000348035.9 | TSL:1 MANE Select | c.116A>G | p.Asn39Ser | missense | Exon 3 of 6 | ENSP00000258737.7 | ||
| RAC1 | ENST00000356142.4 | TSL:1 | c.116A>G | p.Asn39Ser | missense | Exon 3 of 7 | ENSP00000348461.4 | ||
| RAC1 | ENST00000488373.5 | TSL:1 | n.347A>G | non_coding_transcript_exon | Exon 4 of 7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1461848Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727226
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 48 Pathogenic:2
Global developmental delay Pathogenic:1
Neurodevelopmental delay Pathogenic:1
Inborn genetic diseases Pathogenic:1
The c.116A>G (p.N39S) alteration is located in exon 3 (coding exon 3) of the RAC1 gene. This alteration results from an A to G substitution at nucleotide position 116, causing the asparagine (N) at amino acid position 39 to be replaced by a serine (S). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant was determined to be de novo in at least one individual with features consistent with RAC1-related neurodevelopmental disorder (Reijnders, 2017; DECIPHER). This amino acid position is highly conserved in available vertebrate species. This missense alteration is located in a region that has a low rate of benign missense variation (Lek, 2016; Firth, 2009). Mouse fibroblast spreading assays and in vivo overexpression assays using zebrafish demonstrated that the variant functions as a dominant-negative allele and results in microcephaly and reduced neuronal proliferation (Reijnders, 2017). This alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic.
not provided Pathogenic:1
Published functional studies demonstrate microcephaly, reduced neuronal proliferation, and cerebellar abnormalities in Zebrafish studies and substrate adhesion-dependent cell spreading in mouse fibroblasts indicating a dominant negative effect (Reijnders et al., 2017); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33302361, 33397633, 28886345, 27479843, 31646703)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at